|
Apoptotic effect of Kyprolis on multiple myeloma KMM-1 cells through p73-mediated induction of G1 cell cycle arrest
|
Alireza Kazemi1   , Mohammad Reza Sadri1 , Ava Safaroghli-Azar1 , Atieh Pourbagheri-Sigaroodi2 , Mehdi Allahbakhshian-Farsani3 , Nader Vazifeh Shiran3 , Davood Bashash4 |
1- Department of Hematology and Blood banking, School of Allied Medicine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2- Department of Biotechnology, Faculty of Advanced Sciences and Technology, Pharmaceutical Science Branch, Islamic Azad University (IAUPS), Tehran, Iran.
3- Department of Hematology and Blood banking, School of Allied Medicine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4- Department of Hematology and Blood banking, School of Allied Medicine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran , d.bashash@sbmu.ac.ir |
|
|
Abstract: (6240 Views) |
Background and Aim: Since proteasome is strongly considered to be involved in the development and progression of a wide variety of hematological malignancies in particular, multiple myeloma, blockage of this hemostasis system with different types of proteasome inhibitors seems to be a promising way of treatment for multiple myeloma. In this study, we investigated the effect of Kyprolis, a new irreversible proteasome inhibitor (PI), on the survival rate of multiple myeloma -derived KMM-1 cell line.
Material and Methods: To evaluate whether inhibition of proteasome using Kyprolis could exert cytotoxic effect in multiple myeloma, KMM-1 cells were cultured with different concentrations (25-150 nM) of the inhibitor for 24 and 48 hours. Then trypan blue exclusion assay, MTT assay, flocytometric cell cycle analysis were performed and we evaluated gene expression changes associated with apoptosis.
Results: The results of this study demonstrated that Kyprolis induced both cytotoxic and anti-proliferative effects on KMM-1 cells. This inhibitor is able to reduce the cell survival and metabolic activity in a dose- and also time-dependent manner (p ≤ 0.001). Moreover, we found that Kyprolis increased cell population in G1 phase of cell cycle to 52.33% probably through up-regulation of p73 gene expression (p ≤ 0.05). Exposing multiple myeloma cells to this proteasome inhibitor also led to induction of apoptosis probably through alterations in the gene expression of pro- and anti-apoptotic related genes (p ≤ 0.05).
Conclusions: The results of this study clearly indicated that Kyprolis had anti-tumor activity against KMM-1 cells.
Key words: Kyprolis, Multiple Myeloma, Apoptosis, Proteasome inhibitor, KMM-1 cell line, Cell cycle.
Received: May 3, 2017 Accepted: Jul 1, 2017 |
|
| Keywords: Kyprolis, Multiple Myeloma, Apoptosis, Proteasome inhibitor, KMM-1 cell line, Cell cycle. |
|
|
Full-Text [PDF 4406 kb]
(1125 Downloads)
|
Type of Study: Original Research |
Subject:
General
Received: 2018/01/22 | Accepted: 2018/01/22 | Published: 2018/01/22
|
|
|
|
|
|
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
